This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Semaglutide Reprograms Macrophages via the GLP-1R/PPARG/ACSL1 Pathway to Suppress Papillary Thyroid Carcinoma Growth.
The Journal of clinical endocrinology and metabolism, 110(10), 2777-2789
Citation
Wang, Longlong; Zhang, Lele; Ma, Runsheng; Zhang, Yifei; Chang, Qungang; Yin, Detao. (2025). Semaglutide Reprograms Macrophages via the GLP-1R/PPARG/ACSL1 Pathway to Suppress Papillary Thyroid Carcinoma Growth.. The Journal of clinical endocrinology and metabolism, 110(10), 2777-2789. https://doi.org/10.1210/clinem/dgaf053